Uncovering silent carriers: Hematological insights and viral burden in incidentally detected hepatitis B virus infection

Table 1 Comparison of significantly altered hematological and biochemical parameters between hepatitis B virus positive patients and healthy controls

Parameters	HBV median (range)	Control median (range)
Hb (g/dL)	11.1 (5.3-17.9)	14.8 (12.4-17)
Total leucocytes (WBC) count/μL	8100 (2800-21000)	7300 (4900-9000)
Platelet count/μL	217000 (45000-543000)	264000 (167000-380000)
RBC count/μL	4 (2.14-5.94)	Not done
Neutrophils (%)	67 (32-96)	55 (42-68)
Eosinophils (%)	2 (0-9)	2 (1-5)
Basophils (%)	0	Not done
Lymphocytes (%)	23 (2-45)	32.5 (3-38)
Monocytes (%)	8 (1-16)	7 (3-10)
Bilirubin-total (mg/dL)	0.61 (0.16-11.55)	0.855 (0.26-1.59)
Bilirubin-conjugated (mg/dL)	0.285 (0.1-9.24)	Not done
Bilirubin-unconjugated (mg/dL)	0.34 (0.06-3.14)	Not done
SGOT (U/L)	28.5 (10-1237)	18 (15-36)
SGPT (U/L)	22 (9-1731)	16.5 (10-47)
Alk.Pho (U/L)	91 (46-337)	Not done
Protein (total, g/dL)	7 (3.9-8.9)	Not done
Albumin (g/dL)	3.8 (1.8-6.3)	Not done
Globulin (g/dL)	3.1 (1.7-5.3)	Not done
Albumin-globulin ratio	1.24 (0.46-2.05)	Not done

HBV: Hepatitis B virus; Hb: Heamoglobin; WBC: White blood cell; RBC: Red blood cell; SGOT: Serum glutamic-oxaloacetic transaminas; SGPT: Serum glutamic-pyruvic transaminase; Alk.Pho: Alkaline phosphatase.